TY - JOUR
T1 - Three dimensional structure of a bacterial α-l-fucosidase with a 5-membered iminocyclitol inhibitor
AU - Wright, D.W.
AU - Moreno-Vargas, A.J.
AU - Carmona, A.T.
AU - Robina, I.
AU - Davies, G.J.
PY - 2013/8/15
Y1 - 2013/8/15
N2 - Fucosidases, enzymes that cleave fucose from the non-reducing end of a glycan, represent promising medicinal targets reflecting their roles in cancer metastasis, inflammation, host-parasite interactions and the lysosomal storage disorder fucosidosis. The X-ray crystal structures of Bacteroides thetaiotaomicron GH29 α-l-fucosidase (BtFuc2970) in a new crystal form (at a resolution of 1.59 Å) and liganded with a 5-membered iminocyclitol inhibitor (1.73 Å) are reported herein. The 5-membered iminocyclitol binds in a E conformation, mimicking the proposed H half chair transition-state of the enzyme catalysed reaction, and its K for BtFuc2970 was determined as 2 μM. Structural analysis of fucosidase inhibition through 5-membered iminocyclitols will aid in the rational design of more potent fucosidase inhibitors for treatment of a range of medical conditions.
AB - Fucosidases, enzymes that cleave fucose from the non-reducing end of a glycan, represent promising medicinal targets reflecting their roles in cancer metastasis, inflammation, host-parasite interactions and the lysosomal storage disorder fucosidosis. The X-ray crystal structures of Bacteroides thetaiotaomicron GH29 α-l-fucosidase (BtFuc2970) in a new crystal form (at a resolution of 1.59 Å) and liganded with a 5-membered iminocyclitol inhibitor (1.73 Å) are reported herein. The 5-membered iminocyclitol binds in a E conformation, mimicking the proposed H half chair transition-state of the enzyme catalysed reaction, and its K for BtFuc2970 was determined as 2 μM. Structural analysis of fucosidase inhibition through 5-membered iminocyclitols will aid in the rational design of more potent fucosidase inhibitors for treatment of a range of medical conditions.
UR - http://www.scopus.com/inward/record.url?scp=84880573763&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2013.05.056
DO - 10.1016/j.bmc.2013.05.056
M3 - Article
AN - SCOPUS:84880573763
SN - 0968-0896
VL - 21
SP - 4751
EP - 4754
JO - Bioorganic & Medicinal Chemistry
JF - Bioorganic & Medicinal Chemistry
IS - 16
ER -